Philly corporations are left scrambling to navigate new federal orders on diversity, equity, and inclusion policies. Plus, ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about ... other priorities such as the creation of a new specialty pharmacy business as well as putting ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

Unlike many other drug shortage mitigation solutions in the industry, Cencora negotiates long-term agreements with manufacturers to produce new and additional inventory, increasing the quantity of ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

What’s going on here? Cencora has sweetened its fiscal 2025 profit forecast, capitalizing on a surge in specialty medicine demand, particularly GLP-1 drugs, exceeding market expectations. Cencora, ...

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $ ...